Mullen CA - Search Results

1

Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.

Anderson LD Jr, Mori S, Mann S, Savary CA, Mullen CA. Anderson LD Jr, et al. Among authors: mullen ca. Cancer Res. 2000 Oct 15;60(20):5797-802. Cancer Res. 2000. PMID: 11059776

2

Cellular tumor vaccines administered after T cell-depleted allogeneic bone marrow transplantation induce effective anti-tumor immune responses.

Mundhada S, Shaw J, Mori S, Savary CA, Mullen CA. Mundhada S, et al. Among authors: mullen ca. Leuk Lymphoma. 2005 Apr;46(4):571-80. doi: 10.1080/10428190500032596. Leuk Lymphoma. 2005. PMID: 16019486

3

Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine.

Anderson LD Jr, Petropoulos D, Everse LA, Mullen CA. Anderson LD Jr, et al. Among authors: mullen ca. Cancer Res. 1999 Apr 1;59(7):1525-30. Cancer Res. 1999. PMID: 10197624

4

Immunization of allogeneic bone marrow transplant recipients with tumor cell vaccines enhances graft-versus-tumor activity without exacerbating graft-versus-host disease.

Anderson LD Jr, Savary CA, Mullen CA. Anderson LD Jr, et al. Among authors: mullen ca. Blood. 2000 Apr 1;95(7):2426-33. Blood. 2000. PMID: 10733517 Free article.

5

Bone marrow transplant conditioning intensified with liposomal clodronate to eliminate residual host antigen presenting cells fails to ameliorate GVHD and increases PERI-BMT mortality.

Everse LA, Anderson LD Jr, van Rooijen N, Mullen CA. Everse LA, et al. Among authors: mullen ca. Transplantation. 2001 Mar 15;71(5):611-8. doi: 10.1097/00007890-200103150-00006. Transplantation. 2001. PMID: 11292289

6

Down-regulation of antihost alloreactivity after bone marrow transplant permits relapse of hematological malignancy.

Wang J, Shaw JL, Mullen CA. Wang J, et al. Among authors: mullen ca. Cancer Res. 2002 Jan 1;62(1):208-12. Cancer Res. 2002. PMID: 11782379

7

Ganciclovir chemoablation of herpes thymidine kinase suicide gene-modified tumors produces tumor necrosis and induces systemic immune responses.

Mullen CA, Anderson L, Woods K, Nishino M, Petropoulos D. Mullen CA, et al. Hum Gene Ther. 1998 Sep 20;9(14):2019-30. doi: 10.1089/hum.1998.9.14-2019. Hum Gene Ther. 1998. PMID: 9759929

8

Analysis of immunodominance among minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation.

Mori S, El-Baki H, Mullen CA. Mori S, et al. Among authors: mullen ca. Bone Marrow Transplant. 2003 May;31(10):865-75. doi: 10.1038/sj.bmt.1704021. Bone Marrow Transplant. 2003. PMID: 12748663

9

Augmentation of post transplant immunity: antigen encounter at the time of hematopoietic stem cell transplantation enhances antigen-specific donor T-cell responses in the post transplant repertoire.

Mori S, Kocak U, Shaw JL, Mullen CA. Mori S, et al. Among authors: mullen ca. Bone Marrow Transplant. 2005 Apr;35(8):793-801. doi: 10.1038/sj.bmt.1704883. Bone Marrow Transplant. 2005. PMID: 15750607

10

Influence of tumor vaccines on graft versus tumor activity and graft versus host disease in allogeneic bone marrow transplantation.

Mullen CA. Mullen CA. Leuk Lymphoma. 2002 Mar;43(3):503-10. doi: 10.1080/10428190290011976. Leuk Lymphoma. 2002. PMID: 12002752 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters